Cargando…

Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion

BACKGROUND: Malignant pleural effusions continue to be a common problem in patients with metastatic disease, leading to a significant reduction in quality of life with progressive dyspnea, dry cough, chest pain and reduced physical activity. This study was conducted to compare the efficacy, safety,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Islam M, Dokhan, Ahmed L, El-Sessy, Alaa A, Eltaweel, Mohammed F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423097/
https://www.ncbi.nlm.nih.gov/pubmed/25947235
http://dx.doi.org/10.1186/s13019-015-0270-5
_version_ 1782370147987619840
author Ibrahim, Islam M
Dokhan, Ahmed L
El-Sessy, Alaa A
Eltaweel, Mohammed F
author_facet Ibrahim, Islam M
Dokhan, Ahmed L
El-Sessy, Alaa A
Eltaweel, Mohammed F
author_sort Ibrahim, Islam M
collection PubMed
description BACKGROUND: Malignant pleural effusions continue to be a common problem in patients with metastatic disease, leading to a significant reduction in quality of life with progressive dyspnea, dry cough, chest pain and reduced physical activity. This study was conducted to compare the efficacy, safety, and outcome of Talc Powder Pleurodesis (TPP) with Povidone-iodine Pleurodesis (PIP) through a chest drain as a palliative preventive treatment of recurrent malignant pleural effusion. METHODS: A total of 39 neoplastic patients with recurrent malignant pleural effusion were enrolled in a prospective randomized trial. Twenty-one patients received Talc pleurodesis (group A), and eighteen patients (group B) received Povidone-iodine pleurodesis. The continuous variables were expressed as mean values ± standard deviation (SD) and compared using the unpaired t-test. The discrete variables were expressed as percentage and compared using the chi-square test (χ(2)) test. p-values of less than 0.05 were considered significant. RESULTS: Our study included 11 males and 28 females, the mean age was (71.0 ± 5.0) years for group A and (70.9 ± 5.1) years for group B (non-significant). Post-procedure analgesic requirements were recorded in both groups. Four patients in each group had fever (>38°C) within 48 hours of the procedure. Both groups achieved good symptomatic relief. There were no in-hospital deaths. The mean post-procedure hospital stay was (4.7 ± 1.2) days for group A and (4.2 ± 1.0) for group B (non-significant). At follow-up recurrence of significant pleural effusion requiring intervention was noted in four and five patients in group A and group B, respectively (non-significant difference). CONCLUSION: Povidone-iodine pleurodesis can be considered as a good alternative to Talc pleurodesis for recurrent malignant pleural effusion. The drug is available, cost effective, safe and can be administered through an intercostal drain and repeated if necessary.
format Online
Article
Text
id pubmed-4423097
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44230972015-05-08 Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion Ibrahim, Islam M Dokhan, Ahmed L El-Sessy, Alaa A Eltaweel, Mohammed F J Cardiothorac Surg Research Article BACKGROUND: Malignant pleural effusions continue to be a common problem in patients with metastatic disease, leading to a significant reduction in quality of life with progressive dyspnea, dry cough, chest pain and reduced physical activity. This study was conducted to compare the efficacy, safety, and outcome of Talc Powder Pleurodesis (TPP) with Povidone-iodine Pleurodesis (PIP) through a chest drain as a palliative preventive treatment of recurrent malignant pleural effusion. METHODS: A total of 39 neoplastic patients with recurrent malignant pleural effusion were enrolled in a prospective randomized trial. Twenty-one patients received Talc pleurodesis (group A), and eighteen patients (group B) received Povidone-iodine pleurodesis. The continuous variables were expressed as mean values ± standard deviation (SD) and compared using the unpaired t-test. The discrete variables were expressed as percentage and compared using the chi-square test (χ(2)) test. p-values of less than 0.05 were considered significant. RESULTS: Our study included 11 males and 28 females, the mean age was (71.0 ± 5.0) years for group A and (70.9 ± 5.1) years for group B (non-significant). Post-procedure analgesic requirements were recorded in both groups. Four patients in each group had fever (>38°C) within 48 hours of the procedure. Both groups achieved good symptomatic relief. There were no in-hospital deaths. The mean post-procedure hospital stay was (4.7 ± 1.2) days for group A and (4.2 ± 1.0) for group B (non-significant). At follow-up recurrence of significant pleural effusion requiring intervention was noted in four and five patients in group A and group B, respectively (non-significant difference). CONCLUSION: Povidone-iodine pleurodesis can be considered as a good alternative to Talc pleurodesis for recurrent malignant pleural effusion. The drug is available, cost effective, safe and can be administered through an intercostal drain and repeated if necessary. BioMed Central 2015-05-01 /pmc/articles/PMC4423097/ /pubmed/25947235 http://dx.doi.org/10.1186/s13019-015-0270-5 Text en © Ibrahim et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ibrahim, Islam M
Dokhan, Ahmed L
El-Sessy, Alaa A
Eltaweel, Mohammed F
Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
title Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
title_full Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
title_fullStr Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
title_full_unstemmed Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
title_short Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
title_sort povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423097/
https://www.ncbi.nlm.nih.gov/pubmed/25947235
http://dx.doi.org/10.1186/s13019-015-0270-5
work_keys_str_mv AT ibrahimislamm povidoneiodinepleurodesisversustalcpleurodesisinpreventingrecurrenceofmalignantpleuraleffusion
AT dokhanahmedl povidoneiodinepleurodesisversustalcpleurodesisinpreventingrecurrenceofmalignantpleuraleffusion
AT elsessyalaaa povidoneiodinepleurodesisversustalcpleurodesisinpreventingrecurrenceofmalignantpleuraleffusion
AT eltaweelmohammedf povidoneiodinepleurodesisversustalcpleurodesisinpreventingrecurrenceofmalignantpleuraleffusion